These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 23801824)

  • 1. Coronary atherosclerosis with vulnerable plaque and complicated lesions in transplant recipients: new insight into cardiac allograft vasculopathy by optical coherence tomography.
    Cassar A; Matsuo Y; Herrmann J; Li J; Lennon RJ; Gulati R; Lerman LO; Kushwaha SS; Lerman A
    Eur Heart J; 2013 Sep; 34(33):2610-7. PubMed ID: 23801824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optical coherence tomography for characterization of cardiac allograft vasculopathy in late survivors of pediatric heart transplantation.
    Tomai F; De Luca L; Petrolini A; Di Vito L; Ghini AS; Corvo P; De Persio G; Parisi F; Pongiglione G; Giulia Gagliardi M; Prati F
    J Heart Lung Transplant; 2016 Jan; 35(1):74-79. PubMed ID: 26452998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between markers of plaque vulnerability in optical coherence tomography and atherosclerotic progression in adult patients with heart transplantation.
    Park KH; Sun T; Liu Z; Yang SW; Lennon RJ; Lerman LO; Kushwaha SS; Lerman A
    J Heart Lung Transplant; 2017 Feb; 36(2):185-192. PubMed ID: 27461884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Layered Fibrotic Plaques Are the Predominant Component in Cardiac Allograft Vasculopathy: Systematic Findings and Risk Stratification by OCT.
    Clemmensen TS; Holm NR; Eiskjær H; Løgstrup BB; Christiansen EH; Dijkstra J; Barkholt TØ; Terkelsen CJ; Maeng M; Poulsen SH
    JACC Cardiovasc Imaging; 2017 Jul; 10(7):773-784. PubMed ID: 28330670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrotic Plaque and Microvascular Dysfunction Predict Early Cardiac Allograft Vasculopathy Progression After Heart Transplantation: The Early Post Transplant Cardiac Allograft Vasculopathy Study.
    Chih S; Chong AY; Džavík V; So DY; Aleksova N; Wells GA; Bernick J; Overgaard CB; Stadnick E; Mielniczuk LM; Beanlands RSB; Ross HJ
    Circ Heart Fail; 2023 Jun; 16(6):e010173. PubMed ID: 37165901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optical Coherence Tomography in the Assessment and Management of Cardiac Allograft Vasculopathy.
    Chatterjee A; Shanmugasundaram M; Lee KS; Kazui T; Rajapreyar IN; Acharya D
    Curr Cardiol Rep; 2024 Aug; 26(8):777-782. PubMed ID: 38864982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac allograft vasculopathy can be distinguished from donor-transmitted coronary atherosclerosis by optical coherence tomography imaging in a heart transplantation recipient: double layered intimal thickness.
    Imamura T; Kinugawa K; Murasawa T; Kagami Y; Endo M; Muraoka H; Fujino T; Inaba T; Maki H; Hatano M; Kinoshita O; Nawata K; Kyo S; Komuro I; Ono M
    Int Heart J; 2014; 55(2):178-80. PubMed ID: 24632967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early optical coherence tomography evaluation of donor-transmitted atherosclerosis and cardiac allograft vasculopathy: insights from a prospective, single-center study.
    Takahashi T; Kobayashi Y; Saeed O; Vukelic S; Jorde UP; Shin JJ; Patel SR
    J Heart Lung Transplant; 2023 Dec; 42(12):1678-1687. PubMed ID: 37454771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue characterization of progressive cardiac allograft vasculopathy in patients with everolimus therapy compared with donor-transmitted atherosclerosis assessed using serial intravascular imaging: a case report.
    Watanabe T; Kotani J; Murata Y; Seguchi O; Yanase M; Nakatani T
    Transplant Proc; 2014 Sep; 46(7):2456-61. PubMed ID: 25242801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo comparison between cardiac allograft vasculopathy and native atherosclerosis using near-infrared spectroscopy and intravascular ultrasound.
    Zheng B; Maehara A; Mintz GS; Nazif TM; Waksman Y; Qiu F; Jaquez L; Rabbani LE; Apfelbaum MA; Ali ZA; Dalton K; Xu K; Marboe CC; Mancini DM; Weisz G
    Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):985-91. PubMed ID: 25719180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between the vasa vasorum and the atherosclerotic changes in cardiac allograft vasculopathy: volumetric analysis.
    Park KH; Kwon TG; Matsuzawa Y; Sun T; Liu Z; Lennon RJ; Lerman LO; Kushwaha SS; Lerman A
    Eur Heart J Cardiovasc Imaging; 2016 Mar; 17(3):272-9. PubMed ID: 26657475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuated-Signal Plaque Progression Predicts Long-Term Mortality After Heart Transplantation: IVUS Assessment of Cardiac Allograft Vasculopathy.
    Okada K; Fearon WF; Luikart H; Kitahara H; Otagiri K; Tanaka S; Kimura T; Yock PG; Fitzgerald PJ; Yeung AC; Valantine HA; Khush KK; Honda Y
    J Am Coll Cardiol; 2016 Jul; 68(4):382-92. PubMed ID: 27443435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment and characterization of time-related differences in plaque composition by intravascular ultrasound-derived radiofrequency analysis in heart transplant recipients.
    König A; Kilian E; Sohn HY; Rieber J; Schiele TM; Siebert U; Gothe RM; Reichart B; Klauss V
    J Heart Lung Transplant; 2008 Mar; 27(3):302-9. PubMed ID: 18342753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary imaging of cardiac allograft vasculopathy predicts current and future deterioration of left ventricular function in patients with orthotopic heart transplantation.
    Reddy SA; Khialani BV; Lambert B; Floré V; Brown AJ; Pettit SJ; West NE; Lewis C; Parameshwar J; Bhagra S; Kydd A; Hoole SP
    Clin Transplant; 2022 Feb; 36(2):e14523. PubMed ID: 34724254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of early changes in the coronary artery microstructure after heart transplantation: A prospective optical coherence tomography study.
    Clemmensen TS; Holm NR; Eiskjær H; Jakobsen L; Berg K; Neghabat O; Løgstrup BB; Christiansen EH; Dijkstra J; Terkelsen CJ; Maeng M; Poulsen SH
    J Heart Lung Transplant; 2018 Apr; 37(4):486-495. PubMed ID: 29128426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive Intracoronary Imaging of Cardiac Allograft Vasculopathy: Established Modalities and Emerging Technologies.
    Shahandeh N; Parikh RV
    Interv Cardiol Clin; 2023 Apr; 12(2):269-280. PubMed ID: 36922067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optical coherence tomography and highly sensitivity troponin T for evaluating cardiac allograft vasculopathy.
    Garrido IP; García-Lara J; Pinar E; Pastor-Pérez F; Sánchez-Mas J; Valdés-Chavarri M; Pascual-Figal DA
    Am J Cardiol; 2012 Sep; 110(5):655-61. PubMed ID: 22640973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory burden of cardiac allograft coronary atherosclerotic plaque is associated with early recurrent cellular rejection and predicts a higher risk of vasculopathy progression.
    Raichlin E; Bae JH; Kushwaha SS; Lennon RJ; Prasad A; Rihal CS; Lerman A
    J Am Coll Cardiol; 2009 Apr; 53(15):1279-86. PubMed ID: 19358941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo coronary lesion differentiation with computed tomography angiography and intravascular ultrasound as compared to optical coherence tomography.
    Wieringa WG; Lexis CP; Lipsic E; van der Werf HW; Burgerhof JG; Hagens VE; Bartels GL; Broersen A; Schurer RA; Tan ES; van der Harst P; van den Heuvel AF; Willems TP; Pundziute G
    J Cardiovasc Comput Tomogr; 2017; 11(2):111-118. PubMed ID: 28169175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to Approach the Assessment of Cardiac Allograft Vasculopathy in the Modern Era: Review of Invasive Imaging Modalities.
    Javaheri A; Saha N; Lilly SM
    Curr Heart Fail Rep; 2016 Apr; 13(2):86-91. PubMed ID: 26879390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.